Positron gets OK to develop radiopharmaceuticals in Indiana

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Positron has received a nuclear pharmacy license from the Indiana Board of Pharmacy for its Crown Point, Ind., manufacturing facility.

The Indiana Board of Pharmacy license completes the requirements necessary to amend its Nuclear Regulatory Commission license to allow Positron to manufacture and distribute radiochemicals and radiopharmaceuticals in the U.S. The Fischers, Ind.-based company will begin to produce Indium 111 Oxyquinoline for customer evaluation and commercial sale.

Indium In 111 Oxyquinoline is indicated for the labeling of autologous leukocytes.